Shofu Inc. (TYO:7979)
Japan · Delayed Price · Currency is JPY 1,978.00
-22.00 (-1.10%)
Jul 22, 2025, 2:44 PM JST
Shofu Revenue
In the fiscal year ending March 31, 2025, Shofu had annual revenue of 38.70B JPY with 10.31% growth. Shofu had revenue of 9.85B in the quarter ending March 31, 2025, with 1.82% growth.
Revenue
38.70B
Revenue Growth
+10.31%
P/S Ratio
1.84
Revenue / Employee
27.39M
Employees
1,413
Market Cap
71.09B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 38.70B | 3.62B | 10.31% |
| Mar 31, 2024 | 35.08B | 3.40B | 10.74% |
| Mar 31, 2023 | 31.68B | 3.54B | 12.58% |
| Mar 31, 2022 | 28.14B | 3.46B | 14.01% |
| Mar 31, 2021 | 24.68B | -1.43B | -5.47% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,222.12B |
| Takeda Pharmaceutical Company | 4,581.55B |
| Daiichi Sankyo Company | 1,886.26B |
| HOYA Corporation | 866.03B |
| Terumo | 1,036.17B |
| Otsuka Holdings | 2,393.18B |
| Astellas Pharma | 1,912.32B |
| Shionogi & | 438.27B |